Literature DB >> 3032935

Isolation and characterization of adenosine kinase from Leishmania donovani.

A K Datta, D Bhaumik, R Chatterjee.   

Abstract

Adenosine kinase (ATP:adenosine 5'-phosphotransferase, EC 2.7.1.20) has been purified 3250-fold from Leishmania donovani promastigotes using ion-exchange, gel filtration, and affinity chromatography techniques. Both native and sodium dodecyl sulfate-gel electrophoresis of the enzyme revealed a single polypeptide of around 38,000 molecular weight. Biophysical and biochemical analyses of the enzyme reveal unique characteristics different from those of adenosine kinases from other eukaryotic sources. The isoelectric pH of the enzyme is 8.8. In native acrylamide gels the enzyme moves with an RF of about 0.62. The enzyme displays a maximum activity at pH between 7.5 and 8.5 and is dependent upon an optimum ATP/Mg2+ ratio. ATP at high concentration inhibits the reaction. Adenosine and Mg2+ are not inhibitory. EDTA completely knocks off the activity. Enzyme activity is dependent upon the presence of active thiol group(s) at or near the active center. Under a defined set of conditions the enzyme exhibited an apparent Km for adenosine and ATP of 33 and 50 microM, respectively. Of the nucleoside triphosphates tested ATP and GTP were the most effective phosphate donors. Marginal inhibition of activity was detected with other nucleosides as competitors. However, adenosine analogs, such as 7-deaza-adenosine (tubercidin) and 6-methylmercaptopurine riboside at very low concentrations, were found to be excellent inhibitors and substrates as well. S-Adenosylhomocysteine does not inhibit the reaction even at very high concentration.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032935

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Molecular cloning and expression of adenosine kinase from Leishmania donovani: identification of unconventional P-loop motif.

Authors:  K M Sinha; M Ghosh; I Das; A K Datta
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

Review 2.  Purine salvage in Leishmania: complex or simple by design?

Authors:  Jan M Boitz; Buddy Ullman; Armando Jardim; Nicola S Carter
Journal:  Trends Parasitol       Date:  2012-06-20

3.  Leishmania major encodes an unusual peroxidase that is a close homologue of plant ascorbate peroxidase: a novel role of the transmembrane domain.

Authors:  Subrata Adak; Alok K Datta
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

Review 4.  Biochemistry of the Leishmania species.

Authors:  R H Glew; A K Saha; S Das; A T Remaley
Journal:  Microbiol Rev       Date:  1988-12

5.  Concentration of 2'C-methyladenosine triphosphate by Leishmania guyanensis enables specific inhibition of Leishmania RNA virus 1 via its RNA polymerase.

Authors:  John I Robinson; Stephen M Beverley
Journal:  J Biol Chem       Date:  2018-03-06       Impact factor: 5.157

6.  Homology-model-guided site-specific mutagenesis reveals the mechanisms of substrate binding and product-regulation of adenosine kinase from Leishmania donovani.

Authors:  Rupak Datta; Ishita Das; Banibrata Sen; Anutosh Chakraborty; Subrata Adak; Chhabinath Mandal; Alok K Datta
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

7.  Crystal structure of adenosine kinase from Toxoplasma gondii at 1.8 A resolution.

Authors:  W J Cook; L J DeLucas; D Chattopadhyay
Journal:  Protein Sci       Date:  2000-04       Impact factor: 6.725

8.  Identification and characterization of a unique adenosine kinase from Mycobacterium tuberculosis.

Authors:  Mary C Long; Vincent Escuyer; William B Parker
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

9.  GMP reductase and genetic uncoupling of adenylate and guanylate metabolism in Leishmania donovani parasites.

Authors:  Jan M Boitz; Armando Jardim; Buddy Ullman
Journal:  Mol Biochem Parasitol       Date:  2016-06-22       Impact factor: 1.759

Review 10.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.